Rheumatoid Arthritis Orencia Home infusion / thuis infusie
Conditions
Interventions
Treatment is moved from the hospital to the home situation.
Sponsors
Atrium MC Heerlen
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older; 2. Moderate / severe RA; 3. MTX or TNF-alpha Inadequate responders; 4. At least two treatments with Orencia received in hospital; 5. Working phone available at patients home; 6. GP informed about participation in trial; 7. Patient has a clean and working refridgerator and a clean space to prepare Orencia; 8. Patient signed Informed Consent.
Exclusion criteria
Exclusion criteria: 1. Patient showed adverse events or infusional reaction while treated with Orencia in the hospital; 2. Patient has a cardiovascular problem or an uncontrolled infection; 3. The patient is pregnant or breast feeding; 4. The patient shows a hypersensitivity reaction to Orencia; 5. The patients history contains an analphylactic reaction or a significant allergic reaction; 6. The pation is treated with a biological DMARD; 7. The patient was vaccinated with a live vaccine in the 3 months previous to Orencia treatment; 8. The patients has a poistive TB screening and is not accurately treated; 9. The patient is treated for other indications then specified in the SmPC.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfaction of all parties (incl. patients) measured with questionnaires during month 1, 3 and 6. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Preparation Orencia (experience is documented in the patientbook every visit, the book is collected at the end of the visit); 2. No logistic problems (logistics are monitored by Medizorg every visit); 3. Cost aspect (costs are documented by Medizorg for every visit). Objectives focus only on the location of the treatment. | — |
Contacts
Public ContactM.E. Hartman
Vijzelmolenlaan 9
Outcome results
None listed